Healio Nearly 60% of patients who received an initial course of duloxetine reported reductions in pain associated with chemotherapy-induced peripheral neuropathy, according to study results. Painful chemotherapy-induced neuropathy occurs in 20% to 40% of ...
7thSpace Interactive (press release) Methods: This is a post hoc analysis of two 13-week studies, in which patients were randomized to duloxetine 60 mg/day or placebo. Both studies allowed potential dose changes after 7 weeks of dosing, with Study I re-randomizing duloxetine treated ...
Healio Nearly 60% of patients who received an initial course of duloxetine reported reductions in pain associated with chemotherapy-induced peripheral neuropathy, according to study results. Painful chemotherapy-induced neuropathy occurs in 20% to 40% of ...
Clarksdale Press Register According to the toxicology report, which was also released Friday, McMillian was found had a blood-alcohol level of 0.077 and caffeine, nicotine, marijuana and duloxetine , an anti-depressant, were in his syatem. McMillian's murder made international ... and more »
7thSpace Interactive (press release) Methods: This is a post hoc analysis of two 13-week studies, in which patients were randomized to duloxetine 60 mg/day or placebo. Both studies allowed potential dose changes after 7 weeks of dosing, with Study I re-randomizing duloxetine treated ...
Pain Medicine News Chicago— Duloxetine (Cymbalta, Lilly) can be effective at combating chemotherapy-induced peripheral neuropathy (CIPN), according to a Phase III trial presented at the American Society of Clinical Oncology's annual meeting (abstract CRA9013 ...
Healio Nearly 60% of patients who received an initial course of duloxetine reported reductions in pain associated with chemotherapy-induced peripheral neuropathy, according to study results. Painful chemotherapy-induced neuropathy occurs in 20% to 40% of ...
Oncology Nurse Advisor Ellen M. Lavoie Smith, PhD, of the University of Michigan School of Nursing, Ann Arbor, and colleagues conducted a randomized phase 3 trial to examine whether duloxetine would lessen chemotherapy-induced peripheral neuropathic pain. The study ...
